Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Claya vs Gimme Care

Claya
Graded #264

Lower grade

vs+21.799999999999997
Gimme Care
Graded #23

Higher grade

The verdict

Gimme Care takes it — 84.6/100 to 62.8/100.

Gimme Care grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mid-value both-molecule pricing ($130/$163), verified, and nationwide.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueGimme Care +47
42
89
Dose & formulationGimme Care +5
75
80
Clinical oversightGimme Care +2
82
84
Labs & monitoringGimme Care +29
53
82
FulfillmentGimme Care +20
67
87
Contract termsGimme Care +24
61
85
Claya · left barGimme Care · right bar

The numbers

MetricClayaGimme Care
WeighScore62.8/10084.6/100
GradeCB
Scorecard rank#264#23
Semaglutide$299/mo (compounded)$130/mo
Tirzepatide$299/mo (compounded)$163/mo
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Claya

Graded #264 · C

Strengths

  • Two named licensed clinicians (Habashy, NMD MS and Barber, MD PhD) — rare transparency for compounded GLP-1
  • Two named pharmacy partners with full addresses (RedRock, UT and Healthware, KY)
  • Both injectable and oral-tablet forms offered for semaglutide and tirzepatide
  • Weight-loss money-back guarantee published on the homepage
  • Free expedited shipping included in the monthly price

Where it loses points

  • States-served list not disclosed — you must check at checkout
  • LegitScript certification status not displayed
  • Corporate legal entity not disclosed on the site or privacy policy
  • Oral compounded tablets have weaker efficacy data than injectable semaglutide
  • Intro pricing is higher at refill ($299), erasing the first-month advantage
Gimme Care

Graded #23 · B

Strengths

  • $130 sema / $163 tirz
  • All 50 states, LegitScript-verified
  • Both molecules

Where it loses points

  • Not the cheapest tier
  • Injection-only
  • Monitoring detail limited

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard